GIP

Zepbound Use Associated With Lower Healthcare Costs INDIANAPOLIS, Aug. 26, 2026 — Eli Lilly and Company announced new real-world...

Hong Kong – August 3, 2026 Ascletis Pharma Inc. has initiated a global Phase III clinical development program for...

INDIANAPOLIS, July 23, 2026 Eli Lilly and Company has announced positive topline results from the Phase 3 TRIUMPH-2 and...

INGELHEIM, Germany, July 16, 2026 Boehringer Ingelheim has initiated a Phase II clinical trial evaluating BI 3034701, an investigational...

SAN DIEGO, June 24, 2026 Viking Therapeutics (NASDAQ: VKTX) announced the initiation of a Phase 1 clinical trial evaluating...

VANCOUVER, Canada, June 17, 2026 LIR Life Sciences Corp. announced the successful completion of its comparative preclinical animal study...

SOUTH SAN FRANCISCO, Calif., May 31, 2026 Genentech, a member of the Roche Group, announced that new clinical data...